Article ; Online: Mesenchymal stem cell therapy for immune-modulation: the donor, the recipient, and the drugs in-between.
2014 Volume 23, Issue 9, Page(s) 625–628
Abstract: Adoptive transfer of cultured bone marrow stromal cells (mesenchymal stem cells also known as MSCs) is a promising new way to aid tissue regeneration and treat a wide variety of diseases where regulation of inflammatory responses is derailed. Although ... ...
Abstract | Adoptive transfer of cultured bone marrow stromal cells (mesenchymal stem cells also known as MSCs) is a promising new way to aid tissue regeneration and treat a wide variety of diseases where regulation of inflammatory responses is derailed. Although significant advances have been made in the field, pinpointing important mechanistic details about how MSCs function in vitro and in vivo, there are still many unanswered questions that need to be addressed before welcoming MSCs in the therapeutic arsenal of immune mediated diseases. In this viewpoint, we highlight and discuss a few factors that we believe are critical in terms of therapeutic success employing cultured MSCs. Selecting the right donor population, choosing the best culture conditions and picking the patient population that is most likely to give a favourable therapeutic response is just as important as considering interactions between MSCs and the combination of drugs in the recipient's body. Given the complexity of MSC-host interactions, it is also imperative to develop screening tools that account for as many variables as possible and predict precisely the in vivo response rates before MSCs enter the body. To achieve this, a multidisciplinary approach is required with comprehensive knowledge of basic MSC biology, immunology, pharmacology and good clinical practice. |
---|---|
MeSH term(s) | Adoptive Transfer/methods ; Humans ; Immune System Diseases/immunology ; Immune System Diseases/therapy ; Immunosuppressive Agents/therapeutic use ; Immunotherapy, Adoptive/methods ; Mesenchymal Stem Cell Transplantation/methods ; Mesenchymal Stromal Cells/drug effects ; Mesenchymal Stromal Cells/immunology ; Regeneration/immunology ; Skin Diseases/immunology ; Skin Diseases/therapy ; Tissue Donors |
Chemical Substances | Immunosuppressive Agents |
Language | English |
Publishing date | 2014-09 |
Publishing country | Denmark |
Document type | Journal Article ; Review |
ZDB-ID | 1130936-2 |
ISSN | 1600-0625 ; 0906-6705 |
ISSN (online) | 1600-0625 |
ISSN | 0906-6705 |
DOI | 10.1111/exd.12459 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 3508: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.